Search results
Novavax (NASDAQ:NVAX) Trading 3.5% Higher
ETF DAILY NEWS· 2 weeks agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report)’s stock price traded up 3.5% during mid-day trading on Friday . The stock traded as high as $4.48 and last ...
Shah Capital calls for board shake-up at Novavax (NASDAQ:NVAX)
Seeking Alpha· 2 weeks agoShah Capital, a major shareholder in Novavax, urges board shake-up citing underperformance and...
Shah Capital proposes new directors for Novavax board By Investing.com
Investing.com· 2 weeks agoShah Capital, holding a 6.7% stake in vaccine developer Novavax Inc. (NASDAQ: NASDAQ:NVAX), today...
What's Going On With Novavax Stock Today? - Novavax (NASDAQ:NVAX)
Benzinga· 2 weeks agoNovavax Inc NVAX shares are trading higher Monday after Shah Capital Management reported a 6.66%...
Novavax investor Shah Capital pushes for board shakeup
Reuters· 2 weeks agoThe hedge fund nominated Suresh Katta, founder and CEO of biotech firm Saama, and Venkat Peri, CEO...
Novavax, Inc. (NVAX) vs. Its Peers: A Comparison – News Heater
NewsHeater· 4 days agoThere are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.” The public float for NVAX is 132.98M ...
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
Morningstar· 2 weeks agoHedge fund Shah Capital on Monday called for an "urgent shake up" at the board of Novavax over claims its management has failed to capitalize on safety concerns surrounding ...
12 Most Shorted Stocks in 2024
Insider Monkey via Yahoo Finance· 1 week agoIn this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
What's in Store for Biogen (BIIB) This Earnings Season?
Zacks via Yahoo Finance· 1 week agoBiogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its...